Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you live in Perth and Kinross and you're asking about Mounjaro, the short answer is this: tirzepatide is a prescription-only medicine licensed in the UK for weight management, and the only legal route to it is a clinical assessment by a registered prescriber who then decides whether it is right for you. There is no local dispensary in Perth you can simply walk into and pick it up from, and that is true across Scotland and the rest of the UK. What has changed is that a GPhC-registered online pharmacy can carry out that assessment the same day and deliver your treatment to your Perth address by the next working day, which is why online clinics have become the practical route for most people outside major cities. Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist made by Eli Lilly, and it is the only weight-loss medicine in the UK that activates both of those gut-hormone pathways simultaneously. As a prescription-only medicine, its use is always supervised by a clinician who reviews your full health picture before approving anything.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people in Perth and the surrounding area assume that because there is no specialist obesity clinic nearby, Mounjaro simply isn't available to them. That assumption is understandable, but it is out of date. If you want to understand exactly how the medicine works and what the treatment involves, our full Mounjaro guide covers everything from the science to the practicalities. The prescription process for tirzepatide can be completed entirely online with a properly regulated pharmacy, and the medicine is shipped directly to your address. You don't need to travel to Edinburgh or Glasgow. You don't need a GP referral first (though telling your GP you're starting treatment is encouraged, and good online pharmacies notify your GP as part of their clinical process).
The misconception can also cut the other way: some people in Perth see social-media posts selling weight-loss injections locally, sometimes at prices that look too good to be true, and assume those are legitimate. They are not. The MHRA has seized large quantities of counterfeit weight-loss pens across the UK and warns that fake pens have in some cases contained dangerous substances rather than the medicine described on the label. The only way to know you are getting genuine tirzepatide is to obtain it through a pharmacy you can verify on the GPhC pharmacy register. If a seller offers these medicines without requiring a prescription and clinical assessment, walk away.
Understanding what Mounjaro actually does helps explain why the prescription requirement exists. Tirzepatide slows gastric emptying, increases the hormonal signals that tell your brain you are full, and affects blood-sugar regulation. Those effects interact with other medicines and health conditions in ways that a prescriber needs to screen for. It is not a supplement you titrate yourself.
NICE recommended tirzepatide for NHS use in December 2024 (TA1026), and NHS England has begun a phased rollout. If you are in Scotland, however, access decisions follow Scottish pathways, which currently differ from NHS England's phased cohorts. NHS inform Scotland has guidance on weight-loss medication that reflects the Scottish position. In practice, NHS availability in Tayside and Perth and Kinross remains limited to those meeting strict criteria through specialist referral, and waiting times can be long.
Private treatment is the alternative. A GPhC-registered online pharmacy can accept a consultation, review it the same day, and dispatch the pen if the prescriber approves the treatment. For many Perth residents, that is a working route right now rather than a theoretical one in future years. If you're weighing up whether the cost is reasonable for your situation, our page on whether Mounjaro is worth it covers that honestly, including what the clinical evidence says about long-term outcomes.
One thing worth knowing: some GP practices in Scotland are beginning to engage with the NHS rollout, but uptake is optional for practices and the criteria remain narrow. Checking with your own GP is always sensible, but it is not a prerequisite for private treatment.
Tirzepatide is licensed for adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related health condition such as high blood pressure, high cholesterol, type 2 diabetes, prediabetes, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. The licence is a starting point; the prescriber then checks your medical history, current medicines, and any conditions that would make tirzepatide unsuitable.
Conditions that need careful prescriber discussion include a personal or family history of medullary thyroid carcinoma, MEN2, or a history of pancreatitis. Tirzepatide is not recommended during pregnancy, breastfeeding, or while actively trying to conceive, and it is not licensed for anyone under 18. If you take an oral contraceptive, your prescriber will advise adding a barrier method for the first four weeks of treatment and for four weeks after any dose increase, because tirzepatide's effect on gastric emptying can reduce how reliably the pill is absorbed. There is a fuller explanation of this on the Mounjaro and hormonal cycle page, which also covers what patients commonly notice about their cycle on treatment, including a detailed look at why some people find their period changes or goes missing while on Mounjaro.
None of this is designed to put you off. It is designed to make sure the treatment is safe for you specifically, which is the whole point of the prescription requirement. Our prescribers at nume review every consultation personally.
Treatment begins at 2.5mg, a dose that exists primarily to give your body time to adjust before the therapeutic doses begin. The NHS's own tirzepatide patient information describes the schedule and common effects clearly. Most people experience some nausea after the first injection or after a dose increase; this is very common and usually settles within a few days to two weeks. Eating smaller meals, avoiding rich or fatty food around injection day, and staying hydrated all help.
The pen itself is a pre-filled KwikPen injected once weekly into the abdomen, thigh, or upper arm. It needs to be stored in the fridge. The room-temperature window for a pen already out of the fridge is specific enough that you should check the Patient Information Leaflet rather than rely on general guidance — it varies by product batch and storage conditions.
If you have specific questions about tirzepatide as a medicine, the tirzepatide overview page goes deeper on the science. For the practical question of how to begin, the how to get Mounjaro page explains the step-by-step process from consultation through to delivery. And if you're still weighing up whether a GLP-1 medicine is right for you at all, the broader weight-loss treatment overview sets out the full range of options. When you're ready to take the next step, speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.